Alphatec Holdings, Inc.
Rank #35HypergrowthATEC · Nasdaq · Healthcare
Alphatec Holdings, Inc. (ATEC) — Rank #35 by gross profitability (GP/assets 0.67) · ROE 1187.8% · Piotroski F-Score 5 / 9.
As-of 2026-09-15 · CIK 0001350653 · all metrics point-in-time as of the filing date.
About
Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally.
Show moreShow less
The company manufactures and sells implants, instruments, imaging equipment, and spare parts. It offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; SafeOp Neural InformatiX System that automates electromyographic, somatosensory evoked potential, and motor evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissue; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives.
The company was founded in 1990 and is headquartered in Carlsbad, California.
- Industry
- Medical Devices
- Sector
- Healthcare
- State
- DE
- Filer Category
- Large accelerated filer
- Fiscal Year End
- December 31
- Website
- atecspine.com
Financials
Each fiscal year is read as-of that year’s own 10-K filing, so nothing restated after the fact leaks backwards. Line items this filer never tagged are omitted. Hover or tap a badge for the diagnostic behind it.
| Fiscal year end | 2017-12-31filed 2018-03-09 | 2016-12-31filed 2017-03-31 | 2015-12-31filed 2016-03-15 | 2014-12-31filed 2015-02-27 |
|---|---|---|---|---|
| Operating | ||||
| Depreciation & amortization | 7.5 | 12.4 | 19.0 | 18.4 |
| Stock-based compensation | 3.9 | 1.6 | 2.6 | 4.6 |
| Change in receivables | (4.2) | (8.0) | (1.2) | 1.0 |
| Change in inventory | (0.3) | 5.7 | 5.5 | 4.3 |
| Change in payables | (2.6) | (4.9) | 3.2 | (1.0) |
| Operating cash flow | (8.7) | (10.0) | 10.1 | (20.3) |
| Investing | ||||
| Capital expenditures | 7.6 | 8.9 | 12.2 | 11.3 |
| Acquisitions, net of cash | — | — | 0.0 | 0.0 |
| Investing cash flow | (6.5) | 62.0 | (12.2) | (11.0) |
| Financing | ||||
| Financing cash flow | 17.8 | (43.4) | (6.5) | 30.7 |
| Summary | ||||
| Free cash flow | (16.3) | (18.9) | (2.1) | (31.6) |
Figures are as originally filed with the SEC (point-in-time), not restated, so they can differ slightly from sites that show later-restated numbers. Why point-in-time?